Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3) - Image 1

£57.97

Springer Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3)

Name: Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3)
Brand: Springer
Price: 57.97 GBP
Availability: InStock

Immunology

This is the usual price. Wait for it to drop, or tell us your number.

£58 today · usual range £0–£0 · best ever £49

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 638 days • 3 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £55-61 (341 days, 53.4%)

Price range: £49 - £79

Price levels: 3 price ranges over 638 days

Description

Individualized dosing regimens specific to the patient, infection, bacteria, and antibiotic can optimize outcome. Integration of pharmacokinetic and pharmacodynamic data, called dual individualization, can be accomplished through the use of AUIe. AUIC dosing has been shown to predict bacteriological outcomes, hasten clinical outcomes, reduce the emergence of resistance, and be cost-effective. MPC dosing has been shown to predict the emergence of resistant submutants. AUIC and MPC information can provide guidance as to when low doses can be used, and when higher concentrations are required. This strategy can ensure efficacy, minimize toxicity, reduce the opportunity for resistance to occur, and save money. REFERENCES I. Paladino JA. Streamlining antibiotic therapy: clinical application of pharmacokinetic and pharmacodynamic principles. J Osteopath Med 1991; 5: 16-25. 2. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance - a perspective: report of task force 6. Rev Infect Dis 1987; 9 (suppI3): S297-312. 3. Holmberg SO, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9: 1065-78. 4. Sanders cc. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clin Infect Dis 2001; 32(Suppl I ):S 1-8. 5. Ballow CH, Schentag 11. Trends in antibiotic utilization and bacterial resistance: report of the NNRSG. Diagn Microbiol Infect Dis. 1992; 15(suppl):37S-42S. 6. Rice LB, Eckstein EC, DeVente J, Shlaes OM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118-24.

Key Features

Used Book in Good Condition

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 1402073070
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Immunology
Domain: Amazon UK
Release Date: 31 December 2002
Listed Since: 15 December 2006

Barcode

No barcode data available

Springer Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)

Antibiotics: Methods and Protocols: 1520 (Methods in Molecular Biology, 1520)

Antimicrobial Chemotherapy

Antimicrobial Therapies: Methods and Protocols: 2296 (Methods in Molecular Biology, 2296)

Combination Therapy Against Multidrug Resistance

Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2 (Infectious Disease)

21st Century Challenges in Antimicrobial Therapy and Stewardship (Frontiers in Anti-Infective Agents)

Antibiotics - Therapeutic Spectrum and Limitations (Developments in Microbiology)

Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2

Antimicrobial Therapies: Methods and Protocols: 2296 (Methods in Molecular Biology, 2296)

Antimicrobial Resistance in the Environment

The Ongoing Challenge of Antimicrobial Resistance, An Issue of Infectious Disease Clinics of North America: Volume 34-4 (The Clinics: Internal Medicine, Volume 34-4)

The Chemistry and Biology of Beta-Lactams

Antimicrobials: Synthetic and Natural Compounds

Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)

Antibiotics and Antibiotic Resistance in the Environment

Bacterial Resistance to Antimicrobials

Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance

Antibiotic Resistance: 211 (Handbook of Experimental Pharmacology, 211)

Bacterial Resistance to Antimicrobials

Antibacterial Peptide Protocols: 78 (Methods in Molecular Biology, 78)

Science And Technology Against Microbial Pathogens: Research, Development And Evaluation - Proceedings Of The International Conference On Antimicrobial Research (ICAR2010)

Emerging Trends in Antibacterial Discovery: Answering the Call to Arms

Antibiotics: Current Innovations and Future Trends